Industry

The company’s latest product design innovation makes the product fit and feel like regular underwear RALEIGH, N.C.–(BUSINESS WIRE)–#attindas–Attindas Hygiene Partners is proud to announce its innovative new adult disposable incontinence underwear product in North America. Invisible under clothing while providing up to 100% leak-free protection, the new product leverages Maxi Comfort ultrasonic bonding technology for … [Read more…]

Dr. Thomas, Founder and CEO of Metagenomi, will help company advance its pipeline of RNA-guided programmable precision medicines LAUSANNE, Switzerland and SAN DIEGO–(BUSINESS WIRE)–#RNA—HAYA Therapeutics, SA, a company developing RNA-guided programmable precision medicines focused on long non-coding RNAs (lncRNAs), today announced that Brian C. Thomas, Ph.D., has joined HAYA as Chairperson of the Board of … [Read more…]

TA to Provide Healthy Food Options and Wellness Resources for Professional Drivers WESTLAKE, Ohio–(BUSINESS WIRE)–As TravelCenters of America (Nasdaq: TA) celebrates Driver Appreciation Month in September, the company is demonstrating its commitment to professional drivers by providing more options to make healthy choices while on the road. TA announced a collaboration with Cleveland Clinic, one … [Read more…]

Two CME presentations and a lunch symposium will feature the world’s first implantable shock absorber (ISA) for knee osteoarthritis FREMONT, Calif.–(BUSINESS WIRE)–Moximed, a medical device company on a mission to improve the standard of care for people with knee osteoarthritis (OA), today announced that David R. Diduch, MD, the A.F. Voshell Professor of Sports Medicine, … [Read more…]

MOUNT VERNON, N.Y.–(BUSINESS WIRE)–Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the “Company”), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light (“UVC”) for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically affirms that its pathogen killing technology SteriLumen’s Airocide® and Lumicide are … [Read more…]

Mental health clinicians treating patients with moderate to severe mental health conditions face increased demands on their time. The new Osmind virtual visit feature helps clinicians expand care in a variety of settings with built-in Zoom Video technology SAN FRANCISCO–(BUSINESS WIRE)–#ehr—Osmind, the public benefit corporation helping clinicians and researchers advance life-saving mental health treatment, today … [Read more…]

Pendulum Therapeutics has teamed up with bone health researchers at Australian Catholic University to investigate the impact of a targeted probiotic formulation on bone, muscle, and glucose metabolism in early-stage menopause SAN FRANCISCO–(BUSINESS WIRE)–Pendulum Therapeutics, the biotech company pioneering the next frontier of health through their microbiome-targeted products, today announced Professor Mattias Lorentzon from the … [Read more…]

BOSTON–(BUSINESS WIRE)–#cas13–Carver Biosciences, Inc., a biotech company focused on the development of CRISPR/Cas13 antivirals, today announced the closure of a seed round of funding, led by Khosla Ventures. Carver is focused on using the bacterially derived RNA-directed RNase Cas13 to target respiratory viruses. The company was founded in 2021 by Dr. Cameron Myhrvold, Assistant Professor … [Read more…]

Wapnick brings decades of financial experience to the company as it prepares for commercialization of its smart, mobile hemodialysis platform IRVINE, Calif.–(BUSINESS WIRE)–Diality Inc., a medical technology company developing a smart, mobile hemodialysis platform, today announced the hiring of Pamela Wapnick as chief financial officer. She brings to the company more than 30 years of … [Read more…]

Target knockdown and safety results support continued clinical development Alnylam and Regeneron intend to initiate a Phase 2 study in late 2022 Detailed results to be presented at an upcoming medical congress CAMBRIDGE, Mass. & TARRYTOWN, N.Y.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Regeneron Pharmaceuticals (Nasdaq: REGN) announced today preliminary Phase 1 data supporting the … [Read more…]